Email this article ORTOSTATIChESKAYa GIPOTENZIYa I GIPERTENZIYa POKOYa PRI SINUKLEINOPATIYaKh
- Authors: Litvinenko IV1, Dynin PS1
-
Affiliations:
- ВМедА им. С.М. Кирова
- Issue: Vol 38, No 3 (Прил) (2019)
- Pages: 86-88
- Section: Articles
- URL: https://journal-vniispk.ru/RMMArep/article/view/26143
- DOI: https://doi.org/10.17816/rmmar26143
- ID: 26143
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
I V Litvinenko
ВМедА им. С.М. КироваСанкт-Петербург
P S Dynin
ВМедА им. С.М. КироваСанкт-Петербург
References
- Jellinger K.A., Wenning G.K. Multiple system atrophy: pathogenic mechanisms and biomarkers. J. Neural Transm. 2016 Jun,123(6): P. 555-572. doi: 10.1007/s00702-016-1545-2.
- Low P.A., Tomalia V.A. Orthostatic Hypotension: Mechanisms, Causes, Management. Journal of clinical neurology, 2015, 11(3), P. 220-226. doi: 10.3988/jcn.2015.11.3.220.
- Palma J-A., Kaufmann H. Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension. Mov Disord Clin Pract. 2017 May-Jun,4(3): P. 298-308. doi: 10.1002/mdc3.12478.
- Palma J-A. Autonomic dysfunction in Parkinson’s disease and other synucleinopathies: introduction to the series. Mov Disord. 2018: 33: P. 347-348. doi: 10.1002/mds.27347.
- Ma L.Y., Liu G.L., Wang D.X. et al. Alpha-Synuclein in Peripheral Tissues in Parkinson’s Disease. ACS Chem Neurosci. 2019 Feb 20,10(2): P. 812-823. doi: 10.1021/acschemneuro.8b00383.
- Espay A.J., LeWitt P.A., Hauser R.A. et al. Neurogenic orthostatic hypotension and supine hypertension in Parkinson’s disease and related synucleinopathies: prioritisation of treatment targets. The Lancet Neurology. Lancet Neurol. 2016 Aug,15(9): P. 954-966. doi: 10.1016/S1474-4422(16)30079-5.
- Palma J.-A., Kaufmann H. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies. Mov Disord. 2018,33(3):372-390. doi: 10.1002/mds.27344.
Supplementary files
